• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

TapImmune Inc

+ Add to Watchlist

TPIV:US

1.3600 USD 0.0800 5.56%

As of 20:10:00 ET on 08/01/2014.

Snapshot for TapImmune Inc (TPIV)

Open: 1.4400 Day's Range: 1.3500 - 1.4400 Volume: 9,616
Previous Close: 1.4400 52wk Range: 0.6187 - 7.0000 1-Yr Rtn: -27.95%

Stock Chart for TPIV

No chart data available.
  • TPIV:US 1.3600
  • 1D
  • 1M
  • 1Y
1.4400
Interactive TPIV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TPIV

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -109.0000
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 21.84
Shares Outstanding (M) 16.06
30 Day Average Volume 19,166
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TPIV

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TPIV

TapImmune, Inc. is a biotechnology company that discovers and develops immunotherapeutics aimed at the treatment and eradication of cancer. The Company also develops therapies for infectious diseases, autoimmune disorders, and transplant tissue rejection.

Glynn WilsonChairman/CEO/CFO/SecretaryMark ReddishVP:Product Development
Thad MorrisInvestor Relations
More Company Profile & Key Executives for TPIV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil